Ladenburg analyst Jeffrey Cohen initiated coverage of Beta Bionics (BBNX) with a Buy rating and $31 price target The medical device company ...

Baird has initiated its coverage of newly IPO’d medical device maker Beta Bionics (NASDAQ:BBNX) with a Neutral recommendation ...

Poland's Clone Robotics reveals Protoclone V1, a lifelike android with 200+ degrees of freedom, 1,000 Myofibers, and 500 ...